Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for Burning Rock Biotech (BNR) over the last 6 years, with Dec 2024 value amounting to -$45.9 million.

  • Burning Rock Biotech's Income from Continuing Operations fell 91.19% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 106.92%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's Income from Continuing Operations is -$45.9 million, which was up 49.80% from -$91.4 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Income from Continuing Operations peaked at -$45.9 million during FY2024, and registered a low of -$140.2 million during FY2022.
  • Over the past 3 years, Burning Rock Biotech's median Income from Continuing Operations value was -$91.4 million (recorded in 2023), while the average stood at -$92.5 million.
  • In the last 5 years, Burning Rock Biotech's Income from Continuing Operations slumped by 154.76% in 2020 and then skyrocketed by 49.80% in 2024.
  • Yearly analysis of 5 years shows Burning Rock Biotech's Income from Continuing Operations stood at -$62.4 million in 2020, then slumped by 99.86% to -$124.7 million in 2021, then decreased by 12.43% to -$140.2 million in 2022, then skyrocketed by 34.83% to -$91.4 million in 2023, then spiked by 49.80% to -$45.9 million in 2024.